| | |
| WAIT | 67.040 | David Burrows | Growing at 25%. Vast pipeline with a number of drugs. Lots of news to come over the next year. Wait for some strength to come back in the pharmaceutical sector. | 2005-02-15 | |
| | |
| TOP PICK | 65.920 | David Burrows | Likes to find sectors that have been in a period of decline, out of favour and have become underowned and find companies that have bucked that weakness. They have $2 billion plus drugs, so it's profitable. There are over 10 drugs in the pipeline and a very high growth rate. | 2004-12-21 | |
| | |
| TOP PICK | 61.390 | C. KIm Goodwin | Wall Street is underestimating their pipeline, new drug for multiple sclerosis and their opportunities because of their merger with IDEC. | 2004-05-21 | |
Experts that have talked about Biogen IDEC Inc.